Biocartis Group NV
XBRU:BCART

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
XBRU:BCART
Watchlist
Price: 0.29 EUR Market Closed
Market Cap: 27.2m EUR

Wall Street
Price Targets

BCART Price Targets Summary
Biocartis Group NV

There are no price targets for BCART.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biocartis Group NV Competitors:
Price Targets
SIBN
SI-BONE Inc
51% Upside
AORT
Artivion Inc
24% Upside
688575
Shenzhen YHLO Biotech Co Ltd
17% Upside
AFX
Carl Zeiss Meditec AG
24% Upside
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
23% Upside
NMTC
Neuroone Medical Technologies Corp
170% Upside
EW
Edwards Lifesciences Corp
18% Upside
002901
Double Medical Technology Inc
9% Downside

Revenue
Forecast

Revenue Estimate
Biocartis Group NV

For the last 9 years the compound annual growth rate for Biocartis Group NV's revenue is 24%. The projected CAGR for the next 3 years is 21%.

24%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biocartis Group NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Biocartis Group NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCART's stock price target?
Not Available

BCART doesn't have any price targets made by Wall Street professionals.

What is Biocartis Group NV's Revenue forecast?
Projected CAGR
21%

For the last 9 years the compound annual growth rate for Biocartis Group NV's revenue is 24%. The projected CAGR for the next 3 years is 21%.

Back to Top